JP2017505327A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505327A5
JP2017505327A5 JP2016550611A JP2016550611A JP2017505327A5 JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5 JP 2016550611 A JP2016550611 A JP 2016550611A JP 2016550611 A JP2016550611 A JP 2016550611A JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5
Authority
JP
Japan
Prior art keywords
oxy
pyridin
trifluoromethyl
alkyl
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6532474B2 (ja
JP2017505327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/014380 external-priority patent/WO2015119998A1/en
Publication of JP2017505327A publication Critical patent/JP2017505327A/ja
Publication of JP2017505327A5 publication Critical patent/JP2017505327A5/ja
Application granted granted Critical
Publication of JP6532474B2 publication Critical patent/JP6532474B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550611A 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用 Expired - Fee Related JP6532474B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461936397P 2014-02-06 2014-02-06
US61/936,397 2014-02-06
PCT/US2015/014380 WO2015119998A1 (en) 2014-02-06 2015-02-04 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof

Publications (3)

Publication Number Publication Date
JP2017505327A JP2017505327A (ja) 2017-02-16
JP2017505327A5 true JP2017505327A5 (pt-PT) 2018-03-15
JP6532474B2 JP6532474B2 (ja) 2019-06-19

Family

ID=52484589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550611A Expired - Fee Related JP6532474B2 (ja) 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用

Country Status (14)

Country Link
US (3) US9452986B2 (pt-PT)
EP (1) EP3102569A1 (pt-PT)
JP (1) JP6532474B2 (pt-PT)
KR (1) KR20160118345A (pt-PT)
CN (1) CN106458985B (pt-PT)
AU (1) AU2015214366B2 (pt-PT)
BR (1) BR112016017996A2 (pt-PT)
CA (1) CA2938719A1 (pt-PT)
HK (1) HK1231471A1 (pt-PT)
IL (1) IL247014A0 (pt-PT)
MX (1) MX2016010056A (pt-PT)
RU (1) RU2016135637A (pt-PT)
SG (1) SG11201606367YA (pt-PT)
WO (1) WO2015119998A1 (pt-PT)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
PT3466955T (pt) 2014-01-13 2021-01-29 Aurigene Discovery Tech Ltd Método de preparação de derivados de oxazolo[4,5-b] piridina e tiazolo[4,5-b] piridina como inibidores de irak-4 para o tratamento do cancro
CN106458985B (zh) * 2014-02-06 2019-05-03 艾伯维公司 6-杂芳氧基-和6-芳氧基-喹啉-2-甲酰胺及其用途
EA201692418A1 (ru) * 2014-06-20 2017-04-28 Ауриджен Дискавери Текнолоджиз Лимитед Замещенные индазольные соединения в качестве irak4 ингибиторов
CN107108566B (zh) * 2014-09-11 2020-11-24 詹森药业有限公司 取代的2-氮杂双环化合物以及它们作为食欲素受体调节剂的用途
WO2017062804A1 (en) 2015-10-07 2017-04-13 The Arizona Board Of Regents On Behalf Of The University Of Arizona Crmp2 sumoylation inhibitors and uses thereof
PL3359541T3 (pl) * 2015-10-09 2021-01-11 AbbVie Overseas S.à r.l. N-SULFONYLOWANE PIRAZOLO[3,4-b]PIRYDYNO-6-KARBOKSAMIDY I SPOSÓB ZASTOSOWANIA
JP2020503312A (ja) 2016-12-22 2020-01-30 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 置換1,2,4−チアジアゾリルピロロンおよび1,2,4−チアジアゾリルヒダントイン、ならびにその塩、ならびにその除草剤としての使用
HRP20230657T8 (hr) 2017-03-31 2023-11-10 Aurigene Oncology Limited Spojevi i pripravci za liječenje hematoloških poremećaja
JP7210483B2 (ja) * 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
SG11202002386WA (en) 2017-10-31 2020-04-29 Curis Inc Compounds and compositions for treating hematological disorders
MX2021001636A (es) 2018-09-10 2021-05-12 Kaken Pharma Co Ltd Derivado de amida heteroaromatico y medicamento que contiene el mismo.
BR112021008741A2 (pt) 2018-11-09 2021-08-10 Vivace Therapeutics, Inc. compostos bicíclicos
BR112021013637A2 (pt) * 2019-01-11 2021-09-14 Naegis Pharmaceuticals Inc. Inibidores da síntese de leucotrieno
KR20220016456A (ko) * 2019-04-16 2022-02-09 비바체 테라퓨틱스, 인크. 바이사이클릭 화합물
WO2023138599A1 (zh) * 2022-01-18 2023-07-27 成都康弘药业集团股份有限公司 芳香并环类Nav1.8抑制剂及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1894222A (zh) * 2003-08-05 2007-01-10 沃泰克斯药物股份有限公司 作为电压门控离子通道抑制剂的稠合嘧啶化合物
MX2007004465A (es) * 2004-10-19 2007-05-07 Hoffmann La Roche Derivados de quinolina.
KR20080021030A (ko) 2005-05-16 2008-03-06 버텍스 파마슈티칼스 인코포레이티드 이온 채널 조절인자로서의 바이사이클릭 유도체
GB0513692D0 (en) 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
MX2008002731A (es) * 2005-09-01 2008-03-26 Hoffmann La Roche Diaminopirimidinas como moduladores de p2x3 y p3x2/3.
US7846929B2 (en) 2006-04-26 2010-12-07 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and methods of use
WO2008060789A2 (en) * 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
JP5685203B2 (ja) * 2009-05-29 2015-03-18 ラクオリア創薬株式会社 カルシウムチャネル遮断薬またはナトリウムチャネル遮断薬としてのアリール置換カルボキサミド誘導体
WO2011058766A1 (en) * 2009-11-16 2011-05-19 Raqualia Pharma Inc. Aryl carboxamide derivatives as ttx-s blockers
AR081026A1 (es) * 2010-05-10 2012-05-30 Gilead Sciences Inc Analogos de quinolina y su uso en el tratamiento de enfermedades respiratorias
WO2012053186A1 (en) * 2010-10-18 2012-04-26 Raqualia Pharma Inc. Arylamide derivatives as ttx-s blockers
AU2014212426B8 (en) 2013-01-31 2018-05-10 Vertex Pharmaceuticals Incorporated Quinoline and Quinoxaline Amides as Modulators of Sodium Channels
CN106458985B (zh) * 2014-02-06 2019-05-03 艾伯维公司 6-杂芳氧基-和6-芳氧基-喹啉-2-甲酰胺及其用途

Similar Documents

Publication Publication Date Title
JP2017505327A5 (pt-PT)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
US10988478B1 (en) Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2014506929A5 (pt-PT)
RU2473549C2 (ru) Пиримидиновые соединения, композиции и способы применения
CN117263942A (zh) Shp2磷酸酶抑制剂及其使用方法
JP2015526394A5 (pt-PT)
JP2015537010A5 (pt-PT)
JP2015522002A5 (pt-PT)
JP2018530557A5 (pt-PT)
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
JP2014534976A5 (pt-PT)
JP2017524007A5 (pt-PT)
JP2015533822A5 (pt-PT)
RU2015100209A (ru) Замещенные соединения тиофен- и фуран-конденсированного азолопиримидин-5-(6н)-она
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
AU2022325771A1 (en) Heterocyclic compounds and methods of use
JP2019530739A5 (pt-PT)
KR20190088485A (ko) Gaba a 알파5 pam으로서 신규한 이소옥사졸릴 에터 유도체
RU2020129785A (ru) Фармацевтические производные 6,5-гетеробициклического кольца
AU2022265682A1 (en) 2-aminobenzothiazole compounds and methods of use thereof
TW202321242A (zh) 雜環化合物及使用方法